Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Small cell lung cancer: treatment review.

Samantha Cooper1, Stephen G Spiro

  • 1Department of Thoracic Medicine, University College Hospital, London, UK.

Respirology (Carlton, Vic.)
|April 26, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The experiences of autistic medical students in relation to seeking and receiving online support: A phenomenological study.

PloS one·2026
Same author

The REACH VET Program and Mortality Outcomes Among Veterans at High Risk of Suicide.

JAMA network open·2025
Same author

Novel Utilization of Protrieve™ to Decrease Embolization Risk During Radical Nephrectomy With Inferior Vena Cava (IVC) Thrombectomy: A Case Report.

Cureus·2024
Same author

Low-intensity repetitive transcranial magnetic stimulation is safe and well tolerated by people living with MS - outcomes of the phase I randomised controlled trial (TAURUS).

Multiple sclerosis journal - experimental, translational and clinical·2024
Same author

Co-designing a telepractice journey map with disability customers and clinicians: Partnering with users to understand challenges from their perspective.

Health expectations : an international journal of public participation in health care and health policy·2023
Same author

Sequential screening for lung cancer in a high-risk group: randomised controlled trial: LungSEARCH: a randomised controlled trial of Surveillance using sputum and imaging for the EARly detection of lung Cancer in a High-risk group.

The European respiratory journal·2019

Small cell lung cancer (SCLC) is a leading cause of cancer death globally. This review highlights effective chemo-radiotherapy options for SCLC, emphasizing that older patients respond equally well to treatment.

Area of Science:

  • Oncology
  • Pulmonology
  • Medical Therapeutics

Background:

  • Lung cancer incidence has dramatically increased, becoming the leading cause of cancer mortality worldwide, largely due to smoking.
  • Small cell lung cancer (SCLC) constitutes a significant proportion (nearly 25%) of lung cancer cases.
  • SCLC has historically received less attention despite its high sensitivity to chemo-radiotherapy.

Purpose of the Study:

  • To review and highlight the most effective treatment options for small cell lung cancer.
  • To address the underrepresentation of SCLC in recent research and clinical focus.
  • To emphasize the importance of including elderly patients in SCLC treatment considerations.

Main Methods:

  • Comprehensive review of diverse treatment modalities for small cell lung cancer.

Related Experiment Videos

  • Analysis of recent therapeutic strategies and their outcomes.
  • Evaluation of treatment response, toxicity, and survival in different patient demographics, including the elderly.
  • Main Results:

    • Small cell lung cancer, despite late presentation and high dissemination risk, shows exceptional sensitivity to chemo-radiotherapy.
    • Numerous treatment options have been explored in recent years, with varying degrees of success.
    • Older patients (over 70) demonstrate comparable response rates, toxicity profiles, and outcomes to younger patients.

    Conclusions:

    • Age should not be a contraindication for SCLC treatment; elderly patients benefit significantly from therapy.
    • Continued research and clinical attention are crucial for optimizing SCLC management.
    • The review aims to guide clinicians toward the best available therapeutic strategies for SCLC.